General Information of the Compound
Compound ID
CP0965481
Compound Name
(S)-N-((S)-1-(1-(4-(4-(3-((6-(tert-Butylsulfonyl)-4-((4,5-dimethyl-1H-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)piperazin-1-yl)-benzoyl)piperidin-4-yl)-2-((S)-2-(4-(4-fluorobenzoyl)thiazol-2-yl)-pyrrolidin-1-yl)-2-oxoethyl)-2-(methylamino)propanamide
    Show/Hide
Formula
C56H69FN12O7S2
Molecular Weight
1105.377
Canonical SMILES
CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCN(C(=O)c2ccc(N3CCN(CCCOc4cc5ncnc(Nc6n[nH]c(C)c6C)c5cc4S(=O)(=O)C(C)(C)C)CC3)cc2)CC1
    Show/Hide
InChI
InChI=1S/C56H69FN12O7S2/c1-34-35(2)64-65-50(34)63-51-42-30-47(78(74,75)56(4,5)6)46(31-43(42)59-33-60-51)76-29-9-21-66-25-27-67(28-26-66)41-17-13-39(14-18-41)54(72)68-23-19-37(20-24-68)48(62-52(71)36(3)58-7)55(73)69-22-8-10-45(69)53-61-44(32-77-53)49(70)38-11-15-40(57)16-12-38/h11-18,30-33,36-37,45,48,58H,8-10,19-29H2,1-7H3,(H,62,71)(H2,59,60,63,64,65)/t36-,45-,48-/m0/s1
    Show/Hide
InChIKey
MPGHKLADAVRJOJ-VYFIJJFHSA-N
Physicochemical Property
logP
7.01184
Rotatable Bonds
18
Heavy Atom Count
78
Polar Areas
228.05
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
16
Complexity
78

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
ChEMBL ID
CHEMBL4857717
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01405, Receptor-interacting serine/threonine-protein kinase 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000699 HCC4006 Homo sapiens (Human)  1
1
IC50 = 31.62 nM
   TI
   LI
   LO
   TS